Why Medline Inc.’s (MDLN) Stock Is Up 5.10%
As of Tuesday, September 22, Medline Inc.’s MDLN share price has surged by 5.10%, which has investors questioning if this is right time to sell.Rosalio Madrigal
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Rosalio Madrigal
Tudor Pop
Tudor Pop
Michael Rose
| Share Statistics | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $30,689.7 | $387.9 | 90% |
|
| Shares Out (Mil) | 860.9 | 41.5 | 93% |
|
| Institutional Ownership | 98.2% | 82.9% | 77% |
|
| Float (Mil) | 341.0 | 35.5 | 81% |
|
| Beta | na | 0.86 | na |
|
| Avg Daily Volume (000s) | 10,653 | 347 | 96% |
|
| Price Change (52-week) |
na | 65.2% | na |
|
| Growth | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | na | (5.7%) | na |
|
| EPS (5yr) | na | 10.2% | na |
|
| Dividends (5yr) | na | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.5%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 23 | 18 | 25 | |
| Current EPS | $0.346 | $1.551 | $1.577 | |
| Month Ago EPS | $0.347 | $1.572 | $1.582 | |
| # Rev Up | 4 | 5 | 3 | |
| # Rev Down | 1 | 1 | 2 | |
| Three Months Ago EPS | $0.387 | $1.513 | $1.668 | |
| Year/Year Chg | 401.4% | 8.4% | 26.3% | |
| Financials | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $29,939 | $128 | 94% |
|
| Net Income (TTM) (Mil) | $693 | ($9) | 82% |
|
| EPS (TTM) | $0.799 | ($0.400) | 58% |
|
| Operating Cash Flow (TTM) (Mil) | $1,992 | ($3) | 88% |
|
| Net Cash Flow (TTM) (Mil) | $1,745 | $1 | 97% |
|
| Long-Term Debt (Q1) (Mil) | $12,548 | $25 | 93% |
|
| Enterprise Value (Q1) (Mil) | $45,485 | $381 | 91% |
|
| Valuation | MDLN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.65 | 2.75 | 63% |
|
| P/E | 43.9 | 25.1 | 82% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | MDLN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 25.1% | 59.0% | 28% |
|
| Net Margin | 2.3% | (6.9%) | 39% |
|
| ROA | 1.8% | (12.3%) | 54% |
|
| ROE | 4.9% | (10.8%) | 43% |
|
| Liabilities to Assets | 51.5% | 47.1% | 44% |
|
| F-Score | 5 | 4 | na |
|
Medline Inc. did not pass any screens on 9/29/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors